A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Clinical Trial ID NCT00321464

PubWeight™ 23.90^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00321464

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.	J Clin Oncol	2010	9.29
2	Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.	Eur J Cancer	2012	4.29
3	Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid.	Clin Cancer Res	2012	1.26
4	Therapeutic targets for bone metastases in breast cancer.	Breast Cancer Res	2011	1.16
5	Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.	Support Care Cancer	2013	1.12
6	The role of RANK-ligand inhibition in cancer: the story of denosumab.	Oncologist	2011	1.03
7	Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.	Support Care Cancer	2015	0.99
8	Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.	Cancer	2012	0.99
9	Breast Cancer: Rank Ligand Inhibition.	Breast Care (Basel)	2010	0.88
10	Hypocalcaemia in patients with metastatic bone disease treated with denosumab.	Eur J Cancer	2015	0.84
11	Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland.	Eur J Hosp Pharm Sci Pract	2013	0.84
12	Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.	Ther Adv Med Oncol	2011	0.79
13	Denosumab: A comprehensive review.	South Asian J Cancer	2013	0.79
14	The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.	Eur J Cancer	2015	0.79